Founded by Christophe Buee and Pierre-Nicolas Lebas, Winback designs, manufactures, and distributes innovative medical devices based on three non-invasive technologies: TECAR therapy, cryotherapy, and compression. These solutions are primarily used in therapeutic applications within rehabilitation and sports medicine, aiming to relieve pain, reduce inflammation, and accelerate healing to help patients regain mobility as quickly as possible.
Adviso Partners advised Isatis, Garibaldi, and the shareholder-directors of the Winback Group on the capital reorganisation of the company and the minority investment by Capza.